SAFETY OF MELANOTAN
Early day motion 272, tabled 11 December 2008 by Paul Rowen (Liberal Democrat). Signed by 10 members.
That this House notes with concern the use by British citizens of the medicinal product Melanotan; notes that this product is unlicensed and should not be currently advertised or on the market; calls on the Medicines and Healthcare products Regulatory Agency (MHRA) to increase public awareness of the possible dangers of Melanotan; and further calls on MHRA to ensure that individuals supplying Melanotan online to consumers within the United Kingdom are punished accordingly under medicines legislation.
Signatures by party: Labour 7, Liberal Democrat 3.